Upstream Bio

UPB

6.5602.34% ( +0.150 )

Trading: Jul 30, 14:21:10 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Upstream Bio(UPB) predict that the Revenue is 1.034 M (+82.69%), Beat estimate;the EBIT is -43.62 M (-36.24%), Beat estimate;the EPS is -0.75 (-47.06%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.00B82.69%

0.00B38.66%

+0.00B121.35%

EBITExceed expectations

-0.04B36.24%

-0.04B39.50%

+0.00B3.26%

EPSExceed expectations

-0.7547.06%

-0.753847.79%

+0.00380.73%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD